Compliance certificate for share dematerialisation filed for Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹7.12

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+1.7% vs market

Healthcare Service Provider peers, median of 26sector+0.8%+1.6% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4+0.7+1.7+0.8+1.6

Next day

+0.3-1.0+1.2-0.2+0.5

-1.8-0.3-1.6-0.3-1.5

+5.2-1.9+7.1-2.1+7.3

+0.4-4.5+4.9-2.1+2.6

—-5.5—-2.4—

—-7.3—-2.0—

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Lalchandani Labs submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026. The certificate from registrar Cameo Corporate Services confirms that securities received for dematerialisation from depository participants were processed within the stipulated time, physical certificates were cancelled, and depository names were updated in the register of members.

Likely market impact

Routine compliance filing with no material impact on business or stock price. Standard regulatory requirement for share dematerialisation process.